STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Centene Corp Del Stock Price, News & Analysis

CNC NYSE

Welcome to our dedicated page for Centene Del news (Ticker: CNC), a resource for investors and traders seeking the latest updates and insights on Centene Del stock.

Centene Corporation (NYSE: CNC), a leading provider of government-sponsored healthcare programs, offers investors and stakeholders timely access to its latest developments through this centralized news hub. Track official press releases, regulatory filings, and strategic initiatives from the Fortune 500 company driving innovation in Medicaid managed care and Medicare Advantage plans.

This resource delivers essential updates including quarterly earnings reports, contract awards with state/federal agencies, partnerships advancing telehealth services, and expansions of behavioral health programs. Users will find verified information on Centene’s specialty services like pharmacy benefits management and corrections healthcare solutions.

Bookmark this page for direct access to CNC’s:
• Annual and quarterly financial performance
• Government program enrollment updates
• Strategic acquisitions in healthcare services
• Regulatory compliance milestones

Monitor Centene’s progress in addressing healthcare disparities through its integrated care models and value-based initiatives. Return regularly for unfiltered updates directly from corporate communications and SEC filings.

Rhea-AI Summary

Centene Corporation (NYSE: CNC) announced the sale of two pharmacy businesses, Magellan Rx and PANTHERx, to Prime Therapeutics and a consortium respectively, generating approximately $2.8 billion in proceeds. This move aligns with Centene's strategy to exit the Pharmacy Benefit Management space, enhancing value creation. Magellan Rx, acquired in January 2022, is known for specialty drug management, while PANTHERx, acquired in December 2020, excels in rare pharmacy. The transactions are expected to be neutral to slightly accretive to Centene’s Adjusted Earnings Per Share post-closing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.3%
Tags
none
-
Rhea-AI Summary

Centene Corporation (NYSE: CNC) will present at the Bank of America 2022 Healthcare Conference in Las Vegas from May 9-13, 2022. The company's presentation is scheduled for May 10 at 8:40 a.m. PT, with a live audio webcast available at this link. A replay will be accessible on Centene's website under the Investors section afterwards. Centene is a leading healthcare enterprise focused on providing integrated, cost-effective services, particularly for under-insured and uninsured individuals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.62%
Tags
conferences
-
Rhea-AI Summary

Centene Corporation (NYSE: CNC) reported Q1 2022 results showing a diluted EPS of $1.44 and an adjusted diluted EPS of $1.83, with total revenues of $37.2 billion, up 24% year-over-year. Membership rose by 1.9 million to 26.2 million. The health benefits ratio stood at 87.3%, a slight increase from last year. Additionally, the company raised its 2022 revenue and EPS guidance, projecting adjusted EPS between $5.40 to $5.55.

CEO Sarah London emphasized ongoing operational excellence as key to sustainable growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.51%
Tags
Rhea-AI Summary

On April 21, 2022, Meridian of Michigan highlighted the rising issue of cyberbullying among the youth, emphasizing its negative impacts on mental health. A Pew Research study indicates that 59% of U.S. teens have experienced online harassment. Meridian's Chief Medical Officer, Dr. Kay Judge, notes the challenges this presents for parents and the community. To combat this, Meridian encourages youth participation in the Centene Institute Youth Impact Award for Cyberbullying Prevention, with a submission deadline of May 20, 2022. The initiative aims to promote awareness and prevention strategies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.31%
Tags
none
-
Rhea-AI Summary

Centene Corporation's Board of Directors has accepted the resignation of Leslie V. Norwalk as a Board member. The Board expresses appreciation for her service. The company has been enhancing its corporate governance since November 2021 by appointing five new Board members, refreshing committee chairs, separating the CEO and Chairman roles, and appointing a new lead independent director. The Board supports CEO Sarah London and her leadership team in executing the company's value creation strategy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.92%
Tags
management
-
Rhea-AI Summary

Meridian Michigan has appointed Dr. Kay Judge as its new Chief Medical Officer, effective April 10, 2022. Dr. Judge brings over 20 years of experience from health systems in Michigan and California, including her role as Regional Medical Director at Health Net, a Centene subsidiary. She is recognized for her work in reducing healthcare disparities and implementing technology to enhance health outcomes. Dr. Judge aims to uphold Meridian's reputation for high-quality managed care. Meridian is a subsidiary of Centene Corp. (NYSE: CNC), serving Medicaid and Medicare-Medicaid populations in Michigan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.56%
Tags
management
Rhea-AI Summary

Centene Corporation (NYSE: CNC) will host its 2022 Annual Meeting of Stockholders on April 26, 2022, at 11:00 a.m. ET, following the release of its first-quarter financial results. The meeting will be held at Centene's headquarters in St. Louis, Missouri. Attendees can access a live audio webcast via the company's investor relations website. Centene emphasizes its commitment to providing integrated healthcare services, focusing on underserved populations, including Medicaid and Medicare members.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.57%
Tags
conferences earnings
-
Rhea-AI Summary

Welsh, Carson, Anderson & Stowe (WCAS) announced the appointment of Jesse Hunter as an Operating Partner in its Healthcare Group. Hunter, a former executive at Centene Corporation (NYSE: CNC), brings over 20 years of leadership experience, particularly in Mergers & Acquisitions and strategic growth. During his tenure at Centene, he played a key role in expanding the company into a $125 billion enterprise focused on government healthcare programs. His addition is expected to enhance WCAS's portfolio in managed care and population health.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.84%
Tags
none
-
Rhea-AI Summary

Centene Corporation (NYSE: CNC) has appointed Sarah London as Chief Executive Officer, effective immediately, succeeding Michael Neidorff, who is on medical leave. London, previously Vice Chairman, will focus on enhancing integrated, value-based care. Her leadership in technology and corporate strategy is expected to drive innovation within the company. The Board praised her strategic insight and commitment to member care. Centene serves over 26 million Americans, focusing on providing high-quality, affordable healthcare.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.84%
Tags
management
Rhea-AI Summary

Centene Corporation (NYSE: CNC) announced it will release its 2022 first quarter financial results on April 26, 2022, at 6 a.m. ET. A conference call to discuss the results will follow at 8:30 a.m. ET. Interested parties can join the call by dialing the provided numbers or via a live audio webcast on Centene's website. A replay will be available shortly after the call for 12 months. The Company, a leader in healthcare, focuses on integrated services for government-sponsored programs and emphasizes local outreach to support under-insured individuals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.95%
Tags
conferences earnings

FAQ

What is the current stock price of Centene Del (CNC)?

The current stock price of Centene Del (CNC) is $37.56 as of November 7, 2025.

What is the market cap of Centene Del (CNC)?

The market cap of Centene Del (CNC) is approximately 18.2B.
Centene Corp Del

NYSE:CNC

CNC Rankings

CNC Stock Data

18.24B
489.17M
0.46%
99.27%
3.96%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
ST LOUIS